These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

583 related items for PubMed ID: 16616154

  • 21. Antibodies to Ro and La.
    Reichlin M.
    Ann Med Interne (Paris); 1998 Feb; 149(1):34-41. PubMed ID: 11490515
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Development of autoantibodies before the clinical onset of systemic lupus erythematosus.
    Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB.
    N Engl J Med; 2003 Oct 16; 349(16):1526-33. PubMed ID: 14561795
    [Abstract] [Full Text] [Related]

  • 26. Antimitochondrial antibodies in patients with chronic hepatitis C virus infection: description of 18 cases and review of the literature.
    Ramos-Casals M, Pares A, Jara LJ, Solans R, Viñas O, Vázquez P, Sánchez-Tapias JM, Rodés J, Font J, HISPAMEC Study Group*.
    J Viral Hepat; 2005 Nov 16; 12(6):648-54. PubMed ID: 16255767
    [Abstract] [Full Text] [Related]

  • 27. Similarities and differences between primary and secondary Sjögren's syndrome.
    Hernández-Molina G, Avila-Casado C, Cárdenas-Velázquez F, Hernández-Hernández C, Calderillo ML, Marroquín V, Soto-Abraham V, Recillas-Gispert C, Sánchez-Guerrero J.
    J Rheumatol; 2010 Apr 16; 37(4):800-8. PubMed ID: 20194453
    [Abstract] [Full Text] [Related]

  • 28. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies.
    Pradhan VD, Badakere SS, Bichile LS, Almeida AF.
    J Assoc Physicians India; 2004 Jul 16; 52():533-7. PubMed ID: 15645975
    [Abstract] [Full Text] [Related]

  • 29. Coexistence of serum anti-DNA topoisomerase I and anti-Sm antibodies: report of 3 cases.
    Kameda H, Kuwana M, Hama N, Kaburaki J, Homma M.
    J Rheumatol; 1997 Feb 16; 24(2):400-3. PubMed ID: 9035005
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
    Manoussakis MN, Georgopoulou C, Zintzaras E, Spyropoulou M, Stavropoulou A, Skopouli FN, Moutsopoulos HM.
    Arthritis Rheum; 2004 Mar 16; 50(3):882-91. PubMed ID: 15022331
    [Abstract] [Full Text] [Related]

  • 32. Lower prevalence of extra-glandular manifestations and anti-SSB antibodies in patients with primary Sjögren's syndrome and widespread pain: evidence for a relatively benign subset.
    ter Borg EJ, Kelder JC.
    Clin Exp Rheumatol; 2014 Mar 16; 32(3):349-53. PubMed ID: 24529195
    [Abstract] [Full Text] [Related]

  • 33. Systemic sclerosis-associated Sjögren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients.
    Avouac J, Sordet C, Depinay C, Ardizonne M, Vacher-Lavenu MC, Sibilia J, Kahan A, Allanore Y.
    Arthritis Rheum; 2006 Jul 16; 54(7):2243-9. PubMed ID: 16802363
    [Abstract] [Full Text] [Related]

  • 34. Autoantibodies and rheumatic disorders in a neurology inpatient population: a prospective study.
    Olsen ML, O'Connor S, Arnett FC, Rosenbaum D, Grotta JC, Warner NB.
    Am J Med; 1991 Apr 16; 90(4):479-88. PubMed ID: 1901447
    [Abstract] [Full Text] [Related]

  • 35. Characterization and differentiation of autoimmune versus viral liver involvement in patients with Sjögren's syndrome.
    Ramos-Casals M, Sánchez-Tapias JM, Parés A, Forns X, Brito-Zerón P, Nardi N, Vazquez P, Vélez D, Arias I, Bové A, Plaza J, Rodés J, Font J.
    J Rheumatol; 2006 Aug 16; 33(8):1593-9. PubMed ID: 16881116
    [Abstract] [Full Text] [Related]

  • 36. Association of severe inflammatory polyarthritis in primary Sjögren's syndrome: clinical, serologic, and HLA analysis.
    Mohammed K, Pope J, Le Riche N, Brintnell W, Cairns E, Coles R, Bell DA.
    J Rheumatol; 2009 Sep 16; 36(9):1937-42. PubMed ID: 19487261
    [Abstract] [Full Text] [Related]

  • 37. [Autoantibodies in patients with Sjögren's syndrome and their clinical significance].
    Miyawaki S.
    Nihon Rinsho; 1995 Oct 16; 53(10):2422-8. PubMed ID: 8531349
    [Abstract] [Full Text] [Related]

  • 38. Clinical and immunological characteristics of elderly onset Sjögren's syndrome: a comparison with younger onset disease.
    Tishler M, Yaron I, Shirazi I, Yaron M.
    J Rheumatol; 2001 Apr 16; 28(4):795-7. PubMed ID: 11327252
    [Abstract] [Full Text] [Related]

  • 39. True primary Sjögren's syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis.
    De Vita S, Damato R, De Marchi G, Sacco S, Ferraccioli G.
    Isr Med Assoc J; 2002 Dec 16; 4(12):1101-5. PubMed ID: 12516900
    [Abstract] [Full Text] [Related]

  • 40. Salivary production rates fall with age in subjects having anti-centromere, anti-Ro, and/or anti-La antibodies.
    Takada K, Suzuki K, Okada M, Nakashima M, Ohsuzu F.
    Scand J Rheumatol; 2006 Dec 16; 35(1):23-8. PubMed ID: 16467037
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.